The Race for Diversity in COVID-19 Vaccine Trials

In the frantic race for a COVID-19 vaccine, a longstanding issue in clinical trials persists: the lack of diversity.
 
The long history of abusive research practices has left many people of color distrustful of the medical establishment, making it difficult to recruit them for clinical trials.
 
As Black people are dying of COVID-19 at nearly 2.5X the rate of whites, recruiting a balanced cohort is essential. And that requires extra effort and expense such as community outreach, childcare, and transportation.
 
And what does sufficient diversity look like? There’s no consensus on that—but some scientists argue participants should reflect the burden of disease.
 
JAMA

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top